TSE:MFC

Manulife Financial (MFC.TO)

54.00
+0.50 (0.93%)
as of Jun 5, 2026, 8:00:00 pm Market Open.
1636 watching
0
Investor Insights
star iconJun 5, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by numerous analysts, with many highlighting its robust growth potential, especially in the Asian market and wealth management. The company has successfully increased its dividend yield, currently sitting at approximately 4-5%, while its price-to-earnings (PE) ratio remains attractive compared to peers in the banking sector. Analysts have noted concerns over potential earnings drops but maintain a long-term positive outlook, suggesting that MFC is suitable for income-focused investors. While many emphasize the reliability of MFC's dividend and its strong position in life insurance, there are mixed feelings regarding its growth prospects compared to other financial institutions. Overall, the sentiment leans towards MFC being a solid choice for those seeking steady income and moderate growth, but some experts advise caution regarding market volatility.

consensus icon
Consensus
Positive
valuation icon
Valuation
Fair Value
review icon
Similar
GWO
BUY
A long-term Hold. It will take a long time for them to make any money in China.
TOP PICK
Recent retreat here which happens seldom makes this a good entry point. The risk is the currency, but he is still thinking it will net low double digit returns. (dividend at 3% + stock valuation).
BUY
Likes it. Better way to play the insurance business is with Power Financial since it has a broader category. Likes banks over insurance, but still likes it.
BUY
Likes their exposure in the far east. The company is looking globally. Thinks it's great. Buy and hold.
WATCH
Stock is a little expensive here. Buy if they announce an aquisition.
BUY
Great financial. Good entry to China. Integration of John Hancock has been fantastic.
TOP PICK
(A Top Pick Nov 6/06. Up 8.4%.) Has concerns about the banks but wants to be in the financials and this is a phenomenal company. Earnings are growing at 15%. Have a 17% ROE. Well diversified in products, distribution and geographically.
WEAK BUY
Would buy if had to be involved in financial services. Growth coming form around the world. Likes company.
HOLD
He is looking to buy this in the mid-$30, but if it doesn't get there he will buy it anyway. Very well run company. Should grow at 15%-18% a year over the next number of years.
BUY
One of Canada's great companies. It is doing the things that our banks have not done, aggressively expanding overseas and making itself into a global competitor. Trading at a fairly modest PE multiple. Has room to expand its dividend.
BUY
Has gone nowhere for most of this year. The financials have been pretty disappointing. This one has international growth so it will always be his 1st choice, but Sun Life (SLF-T) is a nice complement because it has a different set of assets. You could buy both and do very well.
HOLD
Will be impacted by the malaise in the financial business. What is needed is the next leg up in the market where financials are leading the pack.
BUY ON WEAKNESS
Looking at this one very closely. Would like it a little bit cheaper. Good market diversification. The only near-term risk is if they did a major acquisition. Excellent management.
COMMENT
Stock has been dead for some time and she can't explain it. Numbers are good and they are executing well in the US.
BUY
Hasn't gone anywhere since November. Well-managed. Did a great acquisition with John Hancock. You'll have to be patient with this one. Solid value at this price.
Showing 1,771 to 1,785 of 2,279 entries